Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results 0 26.11.2024 04:42 The New York Times Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
